TY - JOUR
T1 - Behandlingsniveau og behandlingsstop ved benign lungesygdom
AU - Sørensen, Anita Rath
AU - Bendstrup, Elisabeth
AU - Løkke, Anders
AU - Titlestad, Ingrid Louise
AU - Jensen, Jens Ulrik
AU - Thomsen, Laura
AU - Roberts, Nassim
AU - Gjørup, Pia
AU - Shaker, Saher
AU - Gundestrup, Svend
AU - Wilcke, Torgny
AU - Weinreich, Ulla Møller
AU - Marsaa, Kristoffer
PY - 2018/9/24
Y1 - 2018/9/24
N2 - The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.
AB - The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.
M3 - Tidsskriftartikel
C2 - 30274574
VL - 180
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 39
ER -